210 related articles for article (PubMed ID: 11466912)
1. [Prostate cancer screening].
Saksela E
Duodecim; 1997; 113(9):871. PubMed ID: 11466912
[No Abstract] [Full Text] [Related]
2. [Prostate cancer and medical ethics].
Saksela E
Duodecim; 1997; 113(6):532-6; author reply 536-9. PubMed ID: 11370075
[No Abstract] [Full Text] [Related]
3. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
Hayes JH; Barry MJ; Kantoff PW; Stahl JE
BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
[No Abstract] [Full Text] [Related]
4. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
5. How to use PSA to screen for prostate cancer.
Little B; Young M
Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer.
Harris M
Aust Fam Physician; 2003 Jun; 32(6):395. PubMed ID: 12833759
[No Abstract] [Full Text] [Related]
7. Update on screening for prostate cancer with prostate-specific antigen.
Schmid HP; Riesen W; Prikler L
Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
[TBL] [Abstract][Full Text] [Related]
8. [About Psa-screening].
Hakama M; Auvinen A; Stenman UH; Tammela T
Duodecim; 1996; 112(14):1314-6. PubMed ID: 10596108
[No Abstract] [Full Text] [Related]
9. Contemporary view of prostate cancer diagnosis and treatment.
Costello AJ
Aust Fam Physician; 2003 Jun; 32(6):396-8. PubMed ID: 12833761
[No Abstract] [Full Text] [Related]
10. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
11. Prostate-specific antigen and screening for prostate cancer.
Han M; Gann PH; Catalona WJ
Med Clin North Am; 2004 Mar; 88(2):245-65, ix. PubMed ID: 15049577
[TBL] [Abstract][Full Text] [Related]
12. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
Walsh PC
J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
[No Abstract] [Full Text] [Related]
13. PSA screening.
Cohen S; Schiff S; Kelty P
Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
[No Abstract] [Full Text] [Related]
14. PSA testing.
Frydenberg M
Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
[No Abstract] [Full Text] [Related]
15. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
16. Detection characteristics in randomized prostate screening.
Schröder FH; Roobol MJ
Clin Cancer Res; 2004 Sep; 10(17):5641-2. PubMed ID: 15355886
[No Abstract] [Full Text] [Related]
17. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A
Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825
[TBL] [Abstract][Full Text] [Related]
18. Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.
Rowe EW; Laniado ME; Walker MM; Anup P
BJU Int; 2006 May; 97(5):1039-42. PubMed ID: 16643488
[TBL] [Abstract][Full Text] [Related]
19. Screening for prostate cancer: current recommendations.
Wilson SS; Crawford ED
Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402
[TBL] [Abstract][Full Text] [Related]
20. [Why screen for prostate cancer in Finland?].
Auvinen A; Hakama M; Rannikko S; Stenman UH; Tammela T
Duodecim; 1996; 112(14):1241-3. PubMed ID: 10596093
[No Abstract] [Full Text] [Related]
[Next] [New Search]